© Pint of Science, 2024. All rights reserved.
The results of clinical trials affect us all, so shouldn’t we all have access to findings in a transparent and timely manner? Join us for an evening of discussions, hosted by Mike Taylor (Digital Science), featuring an investigation into clinical trial outcome switching, an introduction to Open Pharma and a Q&A session featuring our expert panel!
Open Pharma – the story so far
Dr Steph Macdonald (on behalf of Open Pharma) (Associate Medical Writer, Oxford PharmaGenesis)
For research to be truly transparent, it must also be accessible and discoverable. The current route to publish industry-funded research is slow, with limited transparency and restricted access to research outputs. Open Pharma began during a discussion over a pint, as to why no one seemed to be doing anything about this flawed model of publishing for industry. In this talk, we will share information on our progress, current projects, and ambitions to build a more transparent and accessible publishing process for industry-funded research, and will ask you what actions you want to see from us.
COMPare – what happened when we tried to correct the record on 58 misreported trials
Dr Henry M Drysdale (Clinical research fellow with the EBM DataLab in Oxford and an NHS junior doctor)
Outcome switching in published clinical trials is already known to be extremely common, even in top medical journals, and many previous studies have documented its prevalence. However, the COMPare team went one step further; they wrote to the journals that published each trial found to contain discrepancies and asked them to correct the record on the individual trials to test the ‘self-correcting’ properties of science. The responses to these letters from journal editors and trial authors were unprecedented and shed light on the reasons why this problem persists.
Panel Discussion - Ask the experts
Dr Tim Koder (Communications Director, Oxford PharmaGenesis)
Georgia Richards (Researcher and DPhil Candidate at the University of Oxford)
Joe Adams (Regional Sales Manager EMEA, Wiley)
Nicholas DeVito (Researcher and DPhil Candidate with the EBM DataLab in Oxford)
Professor Trish Greenhalgh (Professor of Primary Care Health Sciences at Nuffield Department of Primary Care Health Sciences, University of Oxford)
This unique session gives audience members the chance to take control and to question our expert panel, including Professor Trish Greenhalgh of the Nuffield Department of Primary Care Health Sciences, Nick DeVito of the Evidence-Based Medicine DataLab, Wiley’s own Joe Adams and doctoral researcher Georgia Richards.
Map data © OpenStreetMap contributors.